In silico electrophysiological models of infarcted hearts, bio-inspired manufacturing of cell-based therapy products or normothermic perfusion in transplantation of solid organs were just some of the new techniques showcased on the medical symposium “Leading-edge Regenerative Medicine”, organized by CARDIOPATCH’s project partners Clínica Universidad de Navarra (CUN) and CIMA Universidad de Navarra on the 18th of November.
The congress gathered relevant experts from Spain and Portugal that are working on these solutions and 3D printing technologies to make a more pleasant life and improve the quality of life of patients that have suffered a heart attack like a myocardial infarction.
During the event, moderated by CARDIOPATCH’s coordinator Dr. Felipe Prósper and scientific responsible Dr. Beatriz Pelacho, the advances of this initiative, co-funded by the Interreg Sudoe Programme through the European Regional Development Fund (ERDF), to face the number one cause of death globally had their protagonism through the voice of Dr. Ane Miren Zaldua, researcher from the project’s partner Leartiker.
Zaldua presented the three biotechnology products that are being developed in the initiative: the cellularized patch, the 3D system for the transport and production of the patch and the 3D printing device for the non-invasive implementation on the heart.
Other partners of CARDIOPATCH initiative also took part at the biomedical symposium. Dr. Manuel Mazo, from CIMA, introduced the BRAVE project and its bioengineering solutions for the fabrication of human myocardial in lab; Dr. Lina Badimon, from Institut de Recerca de l’Hospital de la Santa Creu i Sant Pau, explained how scientific knowledge can contribute to understanding how cell regeneration occurs after a myocardial infarction; and Dr. Margarida Serra, from Instituto de Biologia Experimental e Tecnológica, talked about bio-inspired manufacturing of cell-based therapy products for heart regenerative medicine.
In the afternoon, Dr. Manuel Mazo guided a session to explain the technologies that are making possible the development of replicas of human organs, which can help to solve the shortage of organs available for transplantation.
The Leading-edge Regenerative Medicine medical symposium was an opportunity to discover innovations in the fields that work CARDIOPATCH but also beyond the initiative.
That’s how Dr. Patxi Larumbe, from Cocuus System Iberica, brought a closer understanding of the role of 3D printing technologies in the food industry giving some examples of aliments made by this technique.
Led by Clínica Universidad de Navarra (CUN), CARDIOPATCH includes partners from Spain, France and Portugal: CIMA Universidad de Navarra, via the Foundation for Applied Medical Research, Leartiker Technology Center, Institut de Recerca de l’Hospital de la Santa Creu i Sant Pau, communication agency GUK, Centre Hospitalier Universitaire de Toulouse, the University of Montpellier (UM) - Institut des Biomolécules Max Mousseron (IBMM), GenIbet Biopharmaceuticals and the Instituto de Biologia Experimental e Tecnológica.
CARDIOPATCH Excellent Network born to advance in the field of Cardiac Regenerative Medicine and 3D printing applied to Myocardial Infarction treatment.
CARDIOPATCH project is co-funded by the Interreg Sudoe Programme through the European Regional Development Fund (ERDF).
CARDIOPATCH project is co-funded by the Interreg Sudoe Programme through the European Regional Development Fund (ERDF).
2021 © cardiopatch.eu. Legal notice / Privacy policy / Cookies policy